Bone remodeling in proximal HA-coated versus uncoated cementless SL-Plus((R)) femoral components: a 5-year follow-up study
- PMID: 20049601
- DOI: 10.1007/s00402-009-1040-4
Bone remodeling in proximal HA-coated versus uncoated cementless SL-Plus((R)) femoral components: a 5-year follow-up study
Abstract
Background and purpose: Bone resorption at the femoral stem due to stress shielding has been particularly observed secondary to cementless hip replacement. This prospective study of 126 total-hip replacements was performed to examine clinical outcomes and changes in peri-prosthetic bone density after implantation of a double-tapered cementless femoral component manufactured with versus without hydroxyapatite (HA) coating.
Methods: Sixty-seven femoral components with and 59 femoral components without proximal HA coating were implanted and examined after a mean follow-up of 5.8 (SD 1.1, 2.8-7.8) years. The Harris hip score (HHS) and plain radiographs were used for clinical and radiological follow-up evaluations. Possible changes in peri-prosthetic bone mineral density (BMD) were measured by dual-energy X-ray absorptiometry (DEXA).
Results: Clinical outcome, measured by HHS, was similar in both groups. On plain radiographs, significantly less radiolucent lines were observed for the coated implants. DEXA revealed a significant increase in BMD at the proximal zones, along the medial side, and at the stem tips in the coated compared with the non-coated implants.
Interpretation: Hydroxyapatite-coated implants yield favorable radiographic characteristics, but no greater clinical benefit after 5 years' implantation.
Similar articles
-
Hydroxyapatite-coated tapered cementless femoral components in total hip arthroplasty.J Arthroplasty. 2007 Jun;22(4 Suppl 1):71-4. doi: 10.1016/j.arth.2007.01.019. J Arthroplasty. 2007. PMID: 17570282 Review.
-
Femoral remodeling after porous-coated total hip arthroplasty with and without hydroxyapatite-tricalcium phosphate coating: a prospective randomized trial.J Arthroplasty. 2001 Aug;16(5):552-8. doi: 10.1054/arth.2001.23721. J Arthroplasty. 2001. PMID: 11503113 Clinical Trial.
-
[Long-term experience with the combined ARBOND hydroxyapatite coating in implant osteointegration].Acta Chir Orthop Traumatol Cech. 2009 Jun;76(3):172-8. Acta Chir Orthop Traumatol Cech. 2009. PMID: 19595277 Czech.
-
Peri-prosthetic bone density after implantation of a custom-made femoral component. A five-year follow-up.J Bone Joint Surg Br. 2006 Apr;88(4):467-71. doi: 10.1302/0301-620X.88B4.16613. J Bone Joint Surg Br. 2006. PMID: 16567780
-
Hydroxyapatite coating on the femoral stem in primary total hip arthroplasty.Orthopedics. 2003 Sep;26(9):913-4. doi: 10.3928/0147-7447-20030901-13. Orthopedics. 2003. PMID: 14503744 Review. No abstract available.
Cited by
-
Influence of Hydroxyapatite Coating for the Prevention of Bone Mineral Density Loss and Bone Metabolism after Total Hip Arthroplasty: Assessment Using 18F-Fluoride Positron Emission Tomography and Dual-Energy X-Ray Absorptiometry by Randomized Controlled Trial.Biomed Res Int. 2020 Feb 22;2020:4154290. doi: 10.1155/2020/4154290. eCollection 2020. Biomed Res Int. 2020. PMID: 32185203 Free PMC article. Clinical Trial.
-
What Is the Risk of Revision Surgery in Hydroxyapatite-coated Femoral Hip Stems? Findings From a Large National Registry.Clin Orthop Relat Res. 2018 Dec;476(12):2353-2366. doi: 10.1097/CORR.0000000000000513. Clin Orthop Relat Res. 2018. PMID: 30303878 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources